{"id":556,"date":"2022-11-18T19:24:19","date_gmt":"2022-11-18T19:24:19","guid":{"rendered":"https:\/\/www.biosyent.com\/?post_type=pressrelease&p=556"},"modified":"2022-11-18T19:25:10","modified_gmt":"2022-11-18T19:25:10","slug":"biosyent-pharma-acquires-exclusive-rights-for-cysview-in-canada","status":"publish","type":"pressrelease","link":"https:\/\/www.biosyent.com\/fr\/pressrelease\/biosyent-pharma-acquires-exclusive-rights-for-cysview-in-canada\/","title":{"rendered":"BioSyent Pharma Acquires Exclusive Rights for CYSVIEW\u00ae in Canada"},"excerpt":{"rendered":"","protected":false},"template":"","class_list":["post-556","pressrelease","type-pressrelease","status-publish","hentry"],"acf":[],"_links":{"self":[{"href":"https:\/\/www.biosyent.com\/fr\/wp-json\/wp\/v2\/pressrelease\/556","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.biosyent.com\/fr\/wp-json\/wp\/v2\/pressrelease"}],"about":[{"href":"https:\/\/www.biosyent.com\/fr\/wp-json\/wp\/v2\/types\/pressrelease"}],"wp:attachment":[{"href":"https:\/\/www.biosyent.com\/fr\/wp-json\/wp\/v2\/media?parent=556"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}